Why Patients Are Comparing Wegovy and Mounjaro
Mounjaro and Wegovy are two of the most effective weight-loss injections available in the UK today. Both are weekly injectable treatments that help reduce appetite and support long-term weight management.
However, with Mounjaro prices set to rise by up to 170% from September 2025, many patients are asking if Wegovy is now the better alternative. This guide explains the differences in results, cost, availability, and what patients should consider before switching.
What Is Wegovy?
- Active ingredient: Semaglutide (the same medicine as Ozempic, but licensed for weight management in the UK).
- How it works: Mimics the GLP-1 hormone to reduce appetite, slow digestion, and help patients feel fuller for longer.
- Weight loss results: On average, 15% body weight reduction in clinical trials.
What Is Mounjaro?
- Active ingredient: Tirzepatide (a newer medicine that acts on two gut hormones – GLP-1 and GIP).
- How it works: Provides dual action for appetite control and improved metabolism.
- Weight loss results: Studies show up to 20% body weight reduction in some patients – slightly higher than Wegovy.
Effectiveness Compared
- Wegovy: Average weight loss of 15% (for someone weighing 100kg, that’s around 15kg).
- Mounjaro: Average weight loss closer to 20% in trials.
Both are highly effective, but Mounjaro may produce slightly greater results. However, the cost difference is now a major factor.
Cost Comparison in the UK
From September 2025, Mounjaro private prices will be:
- 2.5mg – £250
- 5mg – £310
- 7.5mg – £400
- 10mg – £400
- 12.5mg – £500
- 15mg – £550
Wegovy prices at PPRX remain more affordable:
- 0.25mg – £170
- 0.5mg – £180
- 1mg – £200
- 1.7mg – £250
- 2.4mg – £300
For patients starting treatment or on lower doses, Wegovy offers a cheaper entry point, and overall treatment costs are lower than Mounjaro.
NHS Access – Wegovy vs Mounjaro
- Wegovy: Available on the NHS for patients with a BMI of 35+ and weight-related health issues, though supply is limited.
- Mounjaro: Approved for diabetes treatment but not yet available on the NHS for weight loss. This means almost all patients must buy it privately.
Safety and Side Effects
- Wegovy (semaglutide): Common side effects include nausea, diarrhoea, constipation, and stomach pain. These usually improve after the first few weeks.
- Mounjaro (tirzepatide): Similar side effects, with some patients experiencing slightly higher rates of nausea.
Both are considered safe and well-studied, though Wegovy has more established long-term safety data in the UK.
Why Patients Are Switching to Wegovy
- Rising cost of Mounjaro (up to £350 per month at higher doses).
- Wegovy is licensed in the UK specifically for weight management.
- Wegovy is more affordable, starting from just £170 at PPRX.
- Wegovy includes the same proven results for most patients, with clinical evidence of 15% weight loss.
Ordering Wegovy from PPRX
When you buy Wegovy from PPRX, every order includes:
- Wegovy pen
- UK private prescription
- Injection needles
- Cold-pack next-day delivery (to home or hotel)
- Ongoing pharmacist support
- Free consultation form – no hidden fees
How to Get Started
- Fill in the consultation form.
- If approved, order Wegovy from the Wegovy product page.
- Receive discreet next-day delivery anywhere in the UK.
Whether you’re just starting or switching from Ozempic or Mounjaro, we’re here to help.
📞 Get in Touch
Visit www.pprx.co.uk or contact us directly to begin your online consultation.
We offer fast, discreet UK-wide delivery and exceptional support throughout your journey.
Wegovy is a prescription-only medicine. This article is for informational purposes only and does not replace medical advice. Always consult a qualified healthcare provider before starting treatment. nhs
